Turnaround Doubts Grow: Evercore Cuts Nike to In Line, Warns on Wholesale Resets and FY27 Outlook
Latest downgrade highlights execution risks and questions the pace of Nike’s multi-year turnaround.
Latest downgrade highlights execution risks and questions the pace of Nike’s multi-year turnaround.
MacroGenics receives $24.5 million from Sanofi after FDA expands TZIELD approval to children aged 8-17 with newly diagnosed stage 3 Type 1 diabetes.
JPMorgan upgrades IBM to Overweight from Neutral, citing strong second-half 2026 software acceleration, Red Hat OpenShift momentum, and HashiCorp-driven tailwinds.
Shares surged 10% after the news as the company focuses on its core grooming and sun care portfolio.
Despite launching Grow a Garden 2, Roblox saw a 5% year-over-year decline in users. Citi maintains a Buy rating and a $70 price target amid Q2 concerns.
The deal would boost Qualcomm’s AI software capabilities and challenge NVIDIA’s dominance in AI inference.